OAKTREE CAPITAL MANAGEMENT LP has added 246,776,273 shares of $INDV to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $INDV.
INDIVIOR Hedge Fund Activity
We have seen 113 institutional investors add shares of INDIVIOR stock to their portfolio, and 71 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OAKTREE CAPITAL MANAGEMENT LP added 246,776,273 shares (+2241.6%) to their portfolio in Q3 2025, for an estimated $5,949,775,942
- DEERFIELD MANAGEMENT COMPANY, L.P. added 10,567,160 shares (+inf%) to their portfolio in Q2 2025, for an estimated $155,759,938
- FULLER & THALER ASSET MANAGEMENT, INC. added 3,169,895 shares (+inf%) to their portfolio in Q3 2025, for an estimated $76,426,168
- BLACKROCK, INC. added 3,044,560 shares (+53.6%) to their portfolio in Q3 2025, for an estimated $73,404,341
- VANGUARD GROUP INC removed 2,181,496 shares (-38.6%) from their portfolio in Q3 2025, for an estimated $52,595,868
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 1,785,055 shares (-78.6%) from their portfolio in Q2 2025, for an estimated $26,311,710
- POINT72 ASSET MANAGEMENT, L.P. added 1,686,628 shares (+89.4%) to their portfolio in Q2 2025, for an estimated $24,860,896
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INDIVIOR Government Contracts
We have seen $9,335,196 of award payments to $INDV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- INTRANASAL NALMEFENE DRUG DEVICE COMBINATION PRODUCT: $9,329,996
- MCKESSON MAT MEDICATIONS MAR 25: $5,200
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
INDIVIOR Analyst Ratings
Wall Street analysts have issued reports on $INDV in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 10/31/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/30/2025
- Craig-Hallum issued a "Buy" rating on 08/27/2025
- Jefferies issued a "Buy" rating on 07/22/2025
To track analyst ratings and price targets for INDIVIOR, check out Quiver Quantitative's $INDV forecast page.
INDIVIOR Price Targets
Multiple analysts have issued price targets for $INDV recently. We have seen 4 analysts offer price targets for $INDV in the last 6 months, with a median target of $34.5.
Here are some recent targets:
- David Amsellem from Piper Sandler set a target price of $41.0 on 10/31/2025
- Brandon Folkes from HC Wainwright & Co. set a target price of $35.0 on 10/30/2025
- Chase Knickerbocker from Craig-Hallum set a target price of $34.0 on 08/27/2025
- Dennis Ding from Jefferies set a target price of $20.0 on 07/22/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $INDV ticker page for more data.
